HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.

Abstract
The efficacy and biochemical effects of two low-dose thiazide plus potassium-sparing diuretic preparations were compared in the treatment of elderly patients with stable, mild to moderate congestive heart failure. Sixty patients (mean age 80 years) were randomly allocated to treatment with 1 tablet daily of either 25 mg hydrochlorothiazide/2.5 mg amiloride or 25 mg hydrochlorothiazide/50 mg triamterene. The dose was increased to 2 tablets daily if necessary, after 2 weeks, for a further 6 weeks. Patients' response to treatment was assessed at 2, 4 and 8 weeks using a simple clinical scoring system for signs and symptoms of their condition, and routine biochemical analysis was carried out at baseline and the end of treatment. One patient was withdrawn from the study due to a rash which was probably related to hydrochlorothiazide/amiloride treatment. A further 11 patients were excluded from the analysis because of intercurrent illness or inadequate records. Analysis of the results from 48 patients showed that both treatments resulted in an improvement in clinical score and weight reduction, with more than three-quarters of the patients responding to treatment. No serious biochemical disturbances occurred; in particular, no new cases of hyponatraemia (serum sodium less than 130 mmol/l) developed. Both preparations, therefore, were effective and tolerated forms of treatment for mild to moderate congestive heart failure in the elderly and there were no significant differences between them.
AuthorsA K Ghosh, G Mankikar, T Strouthidis, A Windsor, C Long, D R Glover
JournalCurrent medical research and opinion (Curr Med Res Opin) Vol. 10 Issue 9 Pg. 573-9 ( 1987) ISSN: 0300-7995 [Print] England
PMID3436153 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Drug Combinations
  • Hydrochlorothiazide
  • hydrochlorothiazide-triamterene
  • amiloride, hydrochlorothiazide drug combination
  • Amiloride
  • Urea
  • Sodium
  • Potassium
  • Triamterene
Topics
  • Aged
  • Aged, 80 and over
  • Amiloride (therapeutic use)
  • Antihypertensive Agents (therapeutic use)
  • Body Weight (drug effects)
  • Drug Combinations (therapeutic use)
  • Female
  • Heart Failure (blood, drug therapy)
  • Humans
  • Hydrochlorothiazide (therapeutic use)
  • Male
  • Potassium (blood)
  • Random Allocation
  • Sodium (blood)
  • Triamterene (therapeutic use)
  • Urea (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: